Sunday, February 12, 2017 9:01:48 AM
Level 1 evidence is the most reliable studies upon which medical treatment decisions are made, and the criteria for levels 1 through 5 are outlined below:
1. Blinded randomized controlled trial with statistically significant differences and appropriate confidence intervals.
2. Randomized controlled trial without proper randomization, blinding, or poor follow up
3. Case control or retrospective study.
4. Case series. (For example, a paper outlining how I fixed a torn tendon in x number of patients and it worked. The overwhelming majority of published medical literature fits into this category)
5. Expert opinion.
Note that Sucanon outperformed Glyburide in a 6 month randomized double blind placebo controlled trial (level 1 evidence, highest reliability) in terms of fasting blood sugar reduction, excretion of urinary glucose, and glucose tolerance testing.
The trial in prediabetics in which 84% showed normalized HbA1C levels after 12 weeks of Sucanon is level 3 since not placebo controlled but was peer reviewed and presented at the prestigious EASD 2013 annual meeting and published in their journal.
I could claim expert opinion (level 5) based on training but instead claim only that my facts are independently verifiable from public sources so any can check as desired. Note that level 4 and 5 is the usual treatment opinion you get from your doctor if specific higher level evidence is not available or consulted.
Finally, if there is more reliable evidence than level 1 above (double blinded randomized placebo controlled study with statistically significant results, I'm all ears. Other than that the publicly available science speaks for itself regarding the efficacy of Sucanon
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM